Table 1. Synthetic Bone-Cartilage Scaffolds Manufactured Using Various Techniques and Biomaterialsa.
Study | Materials for bone | Materials for cartilage | Scaffold design | Fabrication methods | Mechanical properties (compressive) | Biological aspect |
---|---|---|---|---|---|---|
(24) | PCL with SAPH | PCL with SAPH | Monolithic | AM (FDM) | In vivo study for 3% SAPH-coated PCL-scaffold showed cell proliferation and osteogenic differentiation. | |
(17) | PLGA with nano-HA | PLGA with nano-HA | Monolithic | Thermally induced phase separation, annealing and freeze-drying | EM: 0.55 MPa | Higher viability and proliferation of MSCs as compared to PLGA suggested potential use for the cartilage repair in clinical application. |
(177) | Agarose hydrogel with HA | Agarose hydrogel with HA | Monolithic | Casting | EM: 4.3 kPa | Hydrogel-ceramic composite was cultured using chondrocytes that showed optimal mineral aggregate size and content of the native tissue interface. |
Shear modulus: 8.7 kPa | ||||||
(23) | Chitosan-Gelatin-HAc with GR | Chitosan-Gelatin-HAc | Monolithic (Two types) | 3Dbioprinting | EM 0.06% GR: 8 MPa | Biocompatibility test under interaction with P3 BMSC. |
EM 0% GR: 4 MPa | ||||||
(120) | PLGA with nano-HA | PLGA | Bilayered | Casting and sintering | Bony-layer EM: 142 MPa | High cell viability for the cell analysis with rabbit chondrocytes and BMSCs. |
Cartilage-layer EM: 62 MPa | ||||||
Combined EM: 85 MPa | ||||||
(121) | PLGA-PEG foam | PGA-nonwoven mesh | Bilayered | Seeding each layer of PLGA-PEG foam and PGA separately with periosteal cell and chondrocyte for 1-week (immature) as compared to 4-week (mature) construct demonstrated better cartilage/bone integration. | ||
(115) | PCL with HA | PGA/PLA | Bilayered | AM-FDM | Bony-layer EM: 58 MPa | Successful femoral head tissue regeneration of mice. |
Cartilage-layer EM: 5 MPa | ||||||
(116) | PCL with PDO-nanospheres | PEG-hydrogel with PLGA-nanospheres | Bilayered | Casting and UV-light irradiating | Bony-layer EM: 22 MPa | Improved human MSC adhesion in differentiation to the artificial layers as compared to pure PCL-scaffold. |
Cartilage-layer EM: 6 MPa | ||||||
(118) | PLA with G5 bioglass | PLA | Bilayered | AM | Bony-layer EM: 44 MPa | Addition of G5 bioglass lead to a higher vascularization of the implant and consequently promoted bone regeneration. |
Cartilage-layer EM: 28 MPa | ||||||
(170) | PVA-NOCC (hydrogel) with HA | PVA-NOCC (hydrogel) | Bilayered | Tissue harvesting, casting and freezing | In vivo biocompatibility test using of a rat model showed that the bilayered construct may have a promising potential for osteochondral defect. | |
(171) | HA with polyamide6 | PVA | Bilayered | Freezing-thawing and high-temperature annealing | The evaluation of bilayered scaffolds for biocompatibility, osteogenesis and chondrogenesis using ectopic osteochondral construct showed potentials for in situ osteochondral defect repair. | |
(172) | polyHEMA(38)-hydrogel with HA | polyHEMA(200)-hydrogel with HAc | Bilayered | Sphere-templating and freeze-drying | Dry EM: 39 MPa | Cyto-compatibility test with human MSCs and chondrocytes |
Wet EM: 0.09 MPa | ||||||
(178) | Plasmid BMP-2-activated chitosan-gelatin with HA | Plasmid TGF-β1-activated chitosan-gelatin | Bilayered | Casting, salt-leaching and freeze-drying | Spatially controlled and localized gene-activated bilayered scaffold showed significant cell proliferation and induced cell differentiation for in vitro results of the rabbit knee osteochondral defect model. | |
(15) | Silk fibroin with CaP | Silk fibroin | Bilayered | Salt-leaching and freeze-drying | EM: 0.4 MPa | In vitro tests of rabit bone MSCs supported cell attachment, viability and proliferation in interaction with the scaffold. |
(138) | Agar scaffold | PEGDA with HA | Bilayered | Casting and UV-light irradiating | EM: 145 kPa | The presence of HA increased interfacial shear strength of the scaffold as early as 7 days of in vitro tissue culture enhancing the integration of engineered cartilage to bone. |
Shear strength: 5.9 kPa | ||||||
(30) | PLGA microsphere scaffold | Alginate hydrogel | Multilayered (3 layers) | Sintering and freeze–thawing | EM: 7.8 MPa | The multiphasic scaffold exhibited superior tissue repair efficacy in a rabbit knee defect model with a gradient transition and integration between cartilage-bone tissue. However, after decellularization the tissue repair efficacy of the graft decreased, remaining challenges for the industrialization of the graft. |
(14) | Deep zone: Collagen type-I with HA | Intermediate zone: Collagen type-I and II with HA | Multilayered (3 layers) | Freeze-drying | The Scaffold in a critical-sized defect was tested in vivo in a rabbit knee. | |
Superficial zone: Collagen type-II with HAc | The results showed that it was able to guide the host reparative response leading to tissue regeneration with a distinct zonal organization. | |||||
(173) | Silk fibroin with HA | Silk fibroin | Multilayered (3 layers) | Paraffin-sphere leaching and thermally induced phase separation | Bony-layer EM: 55–110 kPa Cartilage-layer EM: 52–84 kPa | Good biocompatibility results of the multiphasic scaffold supported cell growth and differentiations toward chondrocytes and osteoblasts. Particularly, it showed that the intermediate layer can play a role in preventing mixing cells with each other within the chondral and the bony layers. |
(174) | Chitosan with HA | Chitosan-Silk fibroin | Multilayered (4 layers) | Temperature gradient processing | Full scaffold EM: 150 kPa | 14 days cell culture showed that the scaffolds were able to well support the growth and infiltration of cells, suggesting a promising potential for articular cartilage repair. |
Bone-layer EM: 260 kPa | ||||||
(117) | PCL-β-TPC composite | PCL | Gradient | Hybrid extrusion and electrospinning | Only tensile tests, no compressive tests. | The graded scaffold showed better distributions of various biological factors, including the concentrations of drugs/growth factors, and biodegradation rate required for fabricating complexity of the native tissue. |
EM: 18.5–27.5 kPa | ||||||
UTS: 810–1080 kPa | ||||||
(180) | GelMA-GG-hydrogel with HA | GelMA-GG-hydrogel | Gradient | Casting and freeze-drying | The cell culture results of the graded scaffold showed an upregulation of the prevasculature formation in the bone-like region while it was downregulated in the cartilage-like region. | |
(22) | PNAGA-hydrogel with monomer | PNAGA-hydrogel | Gradient | AM (bioprinting) | EM compressive: 20–137 kPa | The in vivo animal evaluation of biohybrid gradient hydrogel scaffold showed simultaneous regeneration of both cartilage and subchondral bone within osteochondral defects. |
EM tensile: 20–43 kPa | ||||||
Max. tensile strength: 0.41 MPa | ||||||
Max. compressive strength: 137 MPa | ||||||
(179) | PACG-GelMA-hydrogel with bioactive glass | PACG-GelMA-hydrogel with Mn2+ | Gradient | AM (bioprinting) | EM compressive: 837 kPa | In vitro biological experiment and in vivo implantation showed that the biohybrid gradient hydrogel scaffold can facilitate the concurrent regeneration of subchondral bone and cartilage in a rat model. |
EM tensile: 320 kPa | ||||||
Max. tensile strength: 1.1 MPa | ||||||
Max. compressive strength: 12.4 MPa | ||||||
(182) | Collagen with HA | Collagen | Gradient | Casting and diffusion |
The acronyms summarized in this table are PCL = polycaprolactone, SAPH = self-assembling peptide hydrogel, FDM = fused deposition modeling, PLGA = poly(lactide-co-glycolide) acid, HA = hydroxyapatite, EM = elastic modulus, HAc = hyaluronic acid, GR = graphene, PEG = polyethylene glycol, PGA = polyglycolic acid, PDO = poly(dioxanone), PLA = polylactic acid, UV = ultraviolet, PVA = poly vinyl alcohol, NOCC = N,O-carboxymethylated chitosan, HEMA = hydroxyethyl methacrylate, PEGDA = poly(ethylene glycol) diacrylate, CaP = calcium phosphate, TCP = tricalcium phosphate, GelMA = methacrylated gelatin, GG = gellan gum, PNAGA = poly(N-acryloyl glycinamide), PACG = poly(N-acryloyl 2-glycine), Mn2+ = manganese ions, FDM = fused deposition modeling, MSCs = mesenchymal stem cells, BMSCs = bone marrow stem cells.